Imago BioSciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IMGO and buy or sell other stocks, ETFs, and their options commission-free!About IMGO
Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians.
CEOHugh Young Rienhoff, Jr., MD
CEOHugh Young Rienhoff, Jr., MD
Employees—
Employees—
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2012
Founded2012
Employees—
Employees—
IMGO Key Statistics
Market cap1.22B
Market cap1.22B
Price-Earnings ratio-19.67
Price-Earnings ratio-19.67
Dividend yield—
Dividend yield—
Average volume149.88K
Average volume149.88K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$36.09
52 Week high$36.09
52 Week low$11.56
52 Week low$11.56
Stock Snapshot
As of today, Imago BioSciences(IMGO) shares are valued at $36.01. The company's market cap stands at 1.22B, with a P/E ratio of -19.67.
Imago BioSciences(IMGO) stock opened on 2025-11-10 at —. The price climbed to — and dipped to —.
The Imago BioSciences(IMGO)'s current trading volume is 0, compared to an average daily volume of 149.88K.
In the last year, Imago BioSciences(IMGO) shares hit a 52-week high of $36.09 and a 52-week low of $11.56.
In the last year, Imago BioSciences(IMGO) shares hit a 52-week high of $36.09 and a 52-week low of $11.56.
People also own
Based on the portfolios of people who own IMGO. This list is generated using Robinhood data, and it’s not a recommendation.